These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1421281)

  • 1. [Electrophoretic analysis of 53K protein presence in leukocytes of the newborn].
    Paponov VD; Rad'ko SP; Shteĭn EV; Shcheglova EG
    Biull Eksp Biol Med; 1992 May; 113(5):527-9. PubMed ID: 1421281
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electrophoretic detection of protein p53 in human leukocytes].
    Paponov VD; Shcheglova EG; Iarullin NN; Kupsik EG
    Biull Eksp Biol Med; 1985 Aug; 100(8):188-91. PubMed ID: 3161558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrophoretic analysis of the characteristics of the protein composition of leukocytes from Down's syndrome patients].
    Paponov VP; Gromov PS; Kovalev LI; Shcheglova EG; Spitkovskiĭ DM
    Biull Eksp Biol Med; 1985 Jan; 99(1):50-2. PubMed ID: 3155630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers.
    Nagalla SR; Canick JA; Jacob T; Schneider KA; Reddy AP; Thomas A; Dasari S; Lu X; Lapidus JA; Lambert-Messerlian GM; Gravett MG; Roberts CT; Luthy D; Malone FD; D'Alton ME
    J Proteome Res; 2007 Apr; 6(4):1245-57. PubMed ID: 17373838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
    Spencer K
    Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal cell-free nucleic acids in the maternal circulation: new clinical applications.
    Wataganara T; Bianchi DW
    Ann N Y Acad Sci; 2004 Jun; 1022():90-9. PubMed ID: 15251945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal cells in maternal blood as a second non-invasive step for fetal Down syndrome screening.
    Farina A; Bianchi DW
    Prenat Diagn; 1998 Sep; 18(9):983-4. PubMed ID: 9793988
    [No Abstract]   [Full Text] [Related]  

  • 8. [Difference in the protein composition of human leukocytes normally and in aneuploidy].
    Paponov VD; Gromov PS; Krasnov PA; Spitkovskiĭ DM
    Vopr Med Khim; 1981; 27(5):666-8. PubMed ID: 6458942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
    Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
    Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased farnesylation of p21-Ras and neonatal macrosomia in women with gestational diabetes.
    Thureen P; Reece M; Rodden D; Barbour L; Chappell J; Leitner JW; Jones RO; Draznin B
    J Pediatr; 2006 Dec; 149(6):871-3. PubMed ID: 17137910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schwangerschafts protein 1 (SP1) adds little to the age-related detection of fetal Down syndrome in the first trimester of pregnancy.
    Kornman LH; Morssink LP; Ten Hoor KA; De Wolf BT; Kloosterman MD; Beekhuis JR; Mantingh A
    Prenat Diagn; 1998 Oct; 18(10):1086-90. PubMed ID: 9826903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polyacrylamide gel disc-electrophoresis of serum proteins in patients with Turner's, Klinefelter's and Down's syndromes].
    Kulakova TA; Red'kin IuV
    Vopr Med Khim; 1984; 30(3):132-5. PubMed ID: 6236610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fetal alcohol syndrome and trisomy 21].
    Chabrolle JP; Bruel H; Nimubona L; Amusini P
    Arch Pediatr; 2005 Feb; 12(2):217-8. PubMed ID: 15694553
    [No Abstract]   [Full Text] [Related]  

  • 14. Endogenous digoxin-like immunoreactivity during pregnancy and at birth.
    Lupoglazoff JM; Jacqz-Aigrain E; Guyot B; Chappey O; Blot P
    Br J Clin Pharmacol; 1993 Mar; 35(3):251-4. PubMed ID: 8471401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cord serum alpha-fetoprotein and Down's syndrome.
    Cuckle HS; Wald NJ; Lindenbaum RH
    Br J Obstet Gynaecol; 1986 Apr; 93(4):408-10. PubMed ID: 2421759
    [No Abstract]   [Full Text] [Related]  

  • 16. First trimester Down syndrome screening markers in triploidy: a case report.
    Campbell J; Cuckle H; Sehmi I; Jones R
    Prenat Diagn; 1999 Nov; 19(11):1086-8. PubMed ID: 10589071
    [No Abstract]   [Full Text] [Related]  

  • 17. Oligosaccharide variants of hCG-related molecules: potential screening markers for Down syndrome.
    Cole LA; Cermik D; Bahado-Singh R
    Prenat Diagn; 1997 Dec; 17(12):1188-90. PubMed ID: 9467819
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of maternal opiate use in pregnancy on second trimester biochemical markers for Down syndrome.
    Scott GJ; Holding S; Purcell A; Tutty S; Lindow SW
    Prenat Diagn; 2009 Sep; 29(9):863-5. PubMed ID: 19488976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma.
    Kolialexi A; Tsangaris GT; Papantoniou N; Anagnostopoulos AK; Vougas K; Bagiokos V; Antsaklis A; Mavrou A
    Prenat Diagn; 2008 Aug; 28(8):691-8. PubMed ID: 18551720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated, sequential, and contingent screening for Down syndrome - local needs should drive methodology.
    Wyatt P
    Prenat Diagn; 2007 Feb; 27(2):186-7. PubMed ID: 17266162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.